Literature DB >> 892805

Genetic patterns in thalassemia intermedia (constitutional microcytic anemia). Familial, hematologic and biosynthetic studies.

I Bianco, B Graziani, C Carboni.   

Abstract

Globin chain synthesis has been studied in 17 patients with thalassemia intermedia, and their relatives, also investigated by routine hematologic and hemoglobinic tests. The mean a/non a ratio was always around 2.20-2.30. In patients with severe thalassemia major, used as a control, the mean a/non a ratio was significantly higher, that is 3.11-3.07. Therefore, the hypothesis that the cause of the lesser severity of the thalassemia intermedia is a lesser imbalance of globin chain synthesis, is suggested. One or both the parents of patients with thalassemia intermedia have mild beta-thalassemia and normal alpha/beta ratio, whereas the parents of patients with severe thalassemia major show a marked beta-thalassemia and a mean alpha/beta ration of 1.76. These data suggest that genes for beta +-thalassemia are responsible for thalassemia intermedia, and genes for beta o-thalassemia are responsible for thalassemia major. In two patients with thalassemia intermedia, the association of an alpha-thalassemia gene with homozygous beta-thalassemia that it is well known to reduce the globin chain imbalance typical of the beta-thalassemia, has also been observed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 892805     DOI: 10.1159/000152877

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  3 in total

1.  beta+-Thalassemia intermedia with low HbF.

Authors:  M A Zago; F F Costa; C Bottura
Journal:  Klin Wochenschr       Date:  1983-01-17

2.  Thalassaemia intermedia in a family with beta 0-thalassaemia and Hb Hasharon.

Authors:  M A Zago; F F Costa; C Bottura
Journal:  J Med Genet       Date:  1982-12       Impact factor: 6.318

3.  Heterogeneity in beta 0 thalassemia from Algeria: genetic, clinical and molecular studies.

Authors:  M Belhani; F Morlé; P Colonna; J Godet
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.